Guselkumab, an interleukin (IL)-23 inhibitor, effectively treats moderate-to-severe plaque psoriasis.ECLIPSE, was a Phase 3, multicenter, 56-week, double-blinded, active-comparator study of guselku...
1 August 2019 in Journal of Investigative Dermatology